ENG/中
老虎證券
行情
产品介绍
Cash Boost账户
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
澳股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
LUMOS DIAGNOSTICS HOLDINGS L
0.065
-0.005
-7.14%
成交量:
2,116.41萬
成交額:
142.98萬
市值:
4,865.40萬
市盈率:
-4.64
高:
0.073
開:
0.070
低:
0.063
收:
0.070
資料載入中...
總覽
公司
新聞
公告
Lumos Diagnostics Holdings (ASX:LDX) 單日暴漲145%:與香港公司簽署4.9億澳元FebriDx美國市場分銷協議
澳洲财经见闻
·
昨天
Lumos Diagnostics與美國Phase Scientific簽署FebriDx獨家分銷協議,潛在價值3.17億美元
华尔街洞察
·
07-16
Lumos Diagnostics與Phase Scientific就Febridx簽署獨家美國分銷協議
华尔街洞察
·
07-16
澳大利亞Lumos Diagnostics股價飆至兩年新高,美國分銷協議推動大漲
华尔街洞察
·
07-16
萊納斯稀土(LDX.AX)投資者簡報:稀土價格回升推動業績增長
华尔街洞察
·
07-16
LUMOS DIAGNOSTICS HOLDINGS L 投資者簡報邀請
华尔街洞察
·
07-16
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/LDX.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LDX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LDX.AU\",,,,,undefined,":{"symbol":"LDX.AU","market":"AU","secType":"STK","nameCN":"LUMOS DIAGNOSTICS HOLDINGS L","latestPrice":0.065,"timestamp":1752819120000,"preClose":0.07,"halted":0,"volume":21164086,"delay":0,"nameEN":"LUMOS DIAGNOSTICS HOLDINGS L","floatShares":375602340,"shares":748523022,"eps":-0.014005597935434686,"marketStatus":"休市中","change":-0.005,"latestTime":"07-18 16:12:00 AEST","open":0.07,"high":0.073,"low":0.063,"amount":1429785,"amplitude":0.142857,"askPrice":0.067,"askSize":481546,"bidPrice":0.065,"bidSize":47401,"shortable":3,"etf":0,"ttmEps":-0.014005597935434686,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1753056000000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.07,"openAndCloseTimeList":[[1752796800000,1752818400000]],"volumeRatio":1.0693955241538537,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LDX.AU\",,,,,undefined,":{"symbol":"LDX.AU","floatShares":375602340,"roa":"-13.86%","roe":"-52.41%","lyrEps":-0.028511,"volumeRatio":1.0693955241538537,"shares":748523022,"dividePrice":0,"high":0.073,"amplitude":0.142857,"preClose":0.07,"low":0.063,"week52Low":0.019,"pbRate":"3.23","psRate":"2.16","week52High":0.08,"institutionHeld":0,"latestPrice":0.065,"committee":-0.820772,"eps":-0.014005597935434686,"divideRate":0,"volume":21164086,"delay":0,"ttmEps":-0.014005597935434686,"open":0.07,"prevYearClose":0.035,"prevWeekClose":0.029,"prevMonthClose":0.027,"prevQuarterClose":0.027,"fiveDayClose":0.029,"twentyDayClose":0.029,"sixtyDayClose":0.026},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LDX.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2552189498","title":"Lumos Diagnostics Holdings (ASX:LDX) 單日暴漲145%:與香港公司簽署4.9億澳元FebriDx美國市場分銷協議","url":"https://stock-news.laohu8.com/highlight/detail?id=2552189498","media":"澳洲财经见闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552189498?lang=zh_tw&edition=fundamental","pubTime":"2025-07-18 21:10","pubTimestamp":1752844207,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings Ltd (ASX股票代码:LDX) 股价异动,周三暴涨144.83…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://afndaily.com/lumos-diagnostics-holdings-asxldx-%e5%8d%95%e6%97%a5%e6%9a%b4%e6%b6%a8145%ef%bc%9a%e4%b8%8e%e9%a6%99%e6%b8%af%e5%85%ac%e5%8f%b8%e7%ad%be%e7%bd%b24-9%e4%ba%bf%e6%be%b3%e5%85%83febridx%e7%be%8e/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"1157074216","title":"Lumos Diagnostics與美國Phase Scientific簽署FebriDx獨家分銷協議,潛在價值3.17億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1157074216","media":"华尔街洞察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157074216?lang=zh_tw&edition=fundamental","pubTime":"2025-07-16 09:56","pubTimestamp":1752630995,"startTime":"0","endTime":"0","summary":"澳大利亚医疗诊断企业Lumos Diagnostics宣布与美国生物科技公司Phase Scientific达成里程碑式合作。双方签署为期六年的独家分销协议,Lumos将获得FebriDx快速诊断产品在美国市场的独家经销权。此次战略合作将显著拓展Lumos在美国体外诊断市场的商业版图。根据协议框架,Phase Scientific将负责产品生产供应,而Lumos则主导美国境内的市场推广与渠道建设。随着协议落地实施,Lumos有望通过分级销售提成机制获得持续收入来源,为其全球商业化布局提供关键助力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"1103381129","title":"Lumos Diagnostics與Phase Scientific就Febridx簽署獨家美國分銷協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1103381129","media":"华尔街洞察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103381129?lang=zh_tw&edition=fundamental","pubTime":"2025-07-16 09:40","pubTimestamp":1752630043,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings Ltd(澳大利亚证券交易所代码:LDX)宣布与Phase Scientific达成一项关键独家分销协议,在美国市场推广其产品Febridx。这份为期六年的合约价值可能高达3.17亿美元,其中包括200万美元的即时付款。此举标志着双方在医疗诊断领域的深度合作,为Febridx在美国的推广奠定坚实基础。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU","BK7126"],"gpt_icon":0},{"id":"1184570585","title":"澳大利亞Lumos Diagnostics股價飆至兩年新高,美國分銷協議推動大漲","url":"https://stock-news.laohu8.com/highlight/detail?id=1184570585","media":"华尔街洞察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184570585?lang=zh_tw&edition=fundamental","pubTime":"2025-07-16 09:26","pubTimestamp":1752629205,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics (LDX.AX)股价飙升,价值翻倍至0.080澳元。这一惊人涨幅创下自2023年7月以来最大日内百分比增幅。医疗科技公司签署了针对FebriDx产品的美国分销和供应协议,潜在价值高达3.17亿美元。FebriDx作为一种快速点检测试,通过手指采血帮助临床医生区分细菌性和非细菌性急性呼吸道感染。协议与总部位于香港的PHASE Scientific International达成。交易量激增至约1580万股,远超30天平均的66.3万股。年初至今,股价已上涨108.6%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"1100998429","title":"萊納斯稀土(LDX.AX)投資者簡報:稀土價格回升推動業績增長","url":"https://stock-news.laohu8.com/highlight/detail?id=1100998429","media":"华尔街洞察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100998429?lang=zh_tw&edition=fundamental","pubTime":"2025-07-16 08:37","pubTimestamp":1752626253,"startTime":"0","endTime":"0","summary":"稀土巨头莱纳斯今日向投资者展示最新业务动态,核心财务指标呈现强劲增长态势。二季度营收同比飙升32%,创下三年来最高单季增幅,主要受益于稀土氧化物价格持续回暖及高端磁材需求激增。\"战略部署方面,莱纳斯正同步推进美国德州重稀土分离厂建设,预计2026年投产将显著优化供应链布局。值得注意的是,莱纳斯首次披露西澳卡尔古里裂解浸出厂升级细节。在问答环节,投资者聚焦于印尼稀土进口政策变化的影响。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","LDX.AU"],"gpt_icon":0},{"id":"1136795874","title":"LUMOS DIAGNOSTICS HOLDINGS L 投資者簡報邀請","url":"https://stock-news.laohu8.com/highlight/detail?id=1136795874","media":"华尔街洞察","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136795874?lang=zh_tw&edition=fundamental","pubTime":"2025-07-16 08:37","pubTimestamp":1752626221,"startTime":"0","endTime":"0","summary":"LUMOS DIAGNOSTICS HOLDINGS L 诚挚邀请投资者参与其即将举行的简报会,以深入了解公司最新动态和发展规划。详情请通过指定链接获取会议日程和参与方式。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","LDX.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":6,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LDX.AU\",params:#limit:5,,,undefined,":[{"date":"2024-07-31","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722384000000,"name":null,"time":"","dateTimestamp":1722348000000,"actualEps":null},{"date":"2024-02-28","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1709074800000,"name":null,"time":"","dateTimestamp":1709038800000,"actualEps":null},{"market":"AU","date":"2023-08-30","symbol":"LDX.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1693317600000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LDX.AU\",market:\"AU\",,,undefined,":[]}}